Marker Therapeutics Inc (MRKR)

[microcapbiotech]

"From $13.50 four years ago to today's .28, a loss of 98%... why?"
Well, the most common sense, logical, realistic answer is ... because the FDA trials were NOT as successful as everybody hoped they would be ... and therefore, realistically, the market responded correspondingly negatively.
Not much of a surprise, that is how it generally works.
It is small cap biotech investing, that is how it goes, shall I list 100+ small cap biotech companies that have BOMBED BIG TIME after their trials failed?

"if BP'S did know (that the science is promising), guess where the price may be."
Absolutely correct ... and do you know how and WHEN Big Pharma KNOWS "that the science is promising"?
Well, the most common sense, logical, realistic answer is ... when MRKR HAS successful FDA trials that proves it to them and everybody else.
Not much of a surprise, that is how it generally works.